한글목차

세계의 생명공학 분야 배지, 혈청 및 시약 시장 규모는 2024년 63억 달러로 평가되었습니다. 예측 기간 중 CAGR 8.1%로 성장할 것으로 전망되고, 2029년 말에는 93억 달러에 이를 것으로 예상되고 있습니다.

북미 시장은 2024년 23억 달러를 기록했습니다. 예측 기간 동안 CAGR은 8.4%를 나타낼 것으로 추정되고 2029년 말에는 35억 달러에 달할 것으로 전망됩니다. 유럽 시장은 2024년 18억 달러에 이르렀습니다. CAGR 7.4%로 성장할 것으로 예측되고, 2029년 말에는 25억 달러에 이를 것으로 추정됩니다.

본 보고서에서는 세계의 생명공학 분야 배지, 혈청 및 시약 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 법 규제 환경, 신기술 및 기술 개발의 동향, 시장 규모 추이와 예측, 각종 구분, 지역별 상세 분석, 경쟁 구도, 주요 기업프로파일 등을 정리했습니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 분석

제2장 시장 개요

• 세포 배양의 유형
• 1차 배양
• 2차 배양
• 배양 배지의 기본 구성 요소
• 완충 시스템
• 페놀 레드
• 무기염
• 아미노산
• 탄수화물
• 단백질 및 펩타이드
• 지방산 및 지질
• 비타민
• 미량 원소
• 배지 보충제
• 항생제
• 세럼
• 세포 배양 용도

제3장 시장 역학

• 시장 역학 : 스냅샷
• 시장 성장 촉진요인
• 바이오의약품에 대한 투자 증가
• 맞춤형 의료 수요 증가
• 기술의 진보
• 고령화 인구 증가와 만성 질환 증가
• 시장 성장 억제요인
• 윤리적 문제와 규제상의 제약
• 숙련된 전문가 부족과 바이오의약품 개발의 고비용
• 시장 기회
• 3D 세포 배양 수요 증가
• 신흥국의 바이오 의약품 수요 증가

제4장 신기술

• 신흥기술
• 세포 배양에 있어서 AI/ML의 응용
• 일회용 기술
• 특허 분석
• 세포 배양 배지
• 세포 배양 시약

제5장 규제 시나리오

• 세계 시장에서의 규제 상황
• 세포 배양 배지
• 혈청

제6장 시장 세분화 분석

• 세계 시장 인사이트
• 세분화의 내역
• 시장 분석 : 제품 유형별
• 시약
• 배지
• 혈청
• 시장 분석 : 최종 사용자별
• 바이오 제약 회사
• 학술연구기관
• 위탁 제조 및 개발 기관(CDMO/CRO)
• 기타
• 지리적 내역
• 시장 분석 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제7장 경쟁 정보

• 개요
• 시장 랭킹 분석
• 전략적 노력
• M&A 활동
• 투자와 확장
• 제품 서론

제8장 생명공학 분야 배지, 혈청 및 시약 시장의 지속가능성 : ESG 관점

• ESG : 서론
• ESG의 지속가능성 동향과 대처
• 환경에의 대처
• 사회와 거버넌스의 대처
• 거버넌스 노력
• ESG 위험 평가 분석
• BCC에 의한 총론

제9장 부록

• 조사 방법
• 출처
• 약어
• 기업 프로파일
• ATCC
• BD
• BIO-TECHNE
• BIOWEST
• CORNING INC.
• DANAHER CORP.
• FUJIFILM IRVINE SCIENTIFIC
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PROMOCELL GMBH
• REPROCELL INC.
• SARTORIUS AG
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.

The North American market for media, sera and reagents in biotechnology is expected to grow from $2.3 billion in 2024 and is projected to reach $3.5 billion by the end of 2029, at a CAGR of 8.4% during the forecast period of 2024 to 2029.

The European market for media, sera and reagents in biotechnology is expected to grow from $1.8 billion in 2024 and is projected to reach $2.5 billion by the end of 2029, at a CAGR of 7.4% during the forecast period of 2024 to 2029.

Report Scope

This report highlights current and future market potential for media, sera and reagents in biotechnology. It provides a detailed analysis of the market drivers, restraints and opportunities. The report includes detailed information on emerging technologies, patent analysis, ESG development, investment outlook and deals. The report also covers market projections through 2029 and presents a competitive landscape. The report provides market estimates and forecasts based on product type, end user and region. The market is segmented by product type into reagents, media and sera. The reagents market is segmented into reagents: biological response modifiers, cell dissociation reagents and others (amino acids, antibiotics, etc.). Market analysis in the media segment is divided into specialty and classical media based on composition. The media are divided into powdered and ready-to-use liquid media based on formulation. Based on serum components, media are segmented into serum-free and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera, including from animal sources such as goats, porcine, rabbits, etc. By end user, the market is segmented into biopharmaceutical companies, academic research institutes, contract research organizations and others. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.

The market is segregated by geographical region into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historical years, 2023 as the base year and 2029 as the forecast year.

Report Includes

• 87 data tables and 55 additional tables
• An analysis of the global market for media, sera and reagents in the biotech industry
• Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the overall market size for media, sera and reagents and their corresponding market share analysis by product type, end use and region
• Discussion of the market potential, and forecasts for the market's segments and sub-segments
• In-depth information concerning market drivers, opportunities, challenges and other demographic and economic factors that will drive demand for media, sera and reagents
• Review of the current market status, key technology issues, industry value chain, Porter's Five Forces, competitive landscape and R&D activity
• A discussion of the industry's ESG challenges and practices
• Market share analysis of the key companies in the industry and coverage of their proprietary technologies, strategic alliances, and other market strategies
• Profiles of the leading companies

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Insights

Chapter 2 Market Overview

• Introduction
• Types of Cell Culture
• Primary Culture
• Secondary Culture
• Basic Components of Culture Media
• Buffering Systems
• Phenol Red
• Inorganic Salts
• Amino Acids
• Carbohydrates
• Proteins and Peptides
• Fatty Acids and Lipids
• Vitamins
• Trace Elements
• Media Supplements
• Antibiotics
• Serum
• Cell Culture Applications

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Rising Investments in Biopharmaceuticals
• Increasing Demand for Personalized Medicines
• Technological Advances
• Rising Aging Population and the Growing Prevalence of Chronic Diseases
• Market Restraints
• Ethical Issues and Regulatory Constraints
• Lack of Skilled Professionals and High Cost of Biopharmaceutical Development
• Market Opportunities
• Rising Demand for 3D Cell Cultures
• Rising Demand for Biopharmaceuticals in Emerging Countries

Chapter 4 Emerging Technologies

• Introduction
• Emerging Technologies
• Application of AI/ML in Cell Culture
• Single Use Technologies
• Patent Analysis
• Cell Culture Media
• Cell Culture Reagents

Chapter 5 Regulatory Scenario

• Regulatory Landscape in the Global Market
• Cell Culture Media
• Sera

Chapter 6 Market Segmentation Analysis

• Global Market Insights
• Segmentation Breakdown
• Market Analysis by Product Type
• Reagents
• Media
• Sera
• Market Analysis by End User
• Biopharmaceutical Companies
• Academic Research Institutes
• Contract Manufacturing and Development Organizations (CDMOs/CROs)
• Other End Users
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 7 Competitive Intelligence

• Overview
• Market Rankings Analysis
• Strategic Initiatives
• M&A Activities
• Investments and Expansions
• Product Introductions

Chapter 8 Sustainability in the Media, Sera and Reagents in Biotechnology Market: An ESG Perspective

• Introduction to ESG
• ESG Sustainability Trends and Initiatives
• Environmental Initiatives
• Social and Governance Initiatives
• Governance Initiatives
• ESG Risk Ratings Analysis
• Concluding Remarks from BCC

Chapter 9 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ATCC
• BD
• BIO-TECHNE
• BIOWEST
• CORNING INC.
• DANAHER CORP.
• FUJIFILM IRVINE SCIENTIFIC
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PROMOCELL GMBH
• REPROCELL INC.
• SARTORIUS AG
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.